Rate My Professor Craig Carr

Dr. Craig Carr serves as Clinical Senior Lecturer in the Anaesthesia and Intensive Care section within the Department of Surgical Sciences at the University of Otago, Dunedin School of Medicine, Division of Health Sciences. Concurrently, he is the Clinical Director of Intensive Care Medicine at Dunedin Hospital under Te Whatu Ora - Southern. His academic background includes an MB ChB from the University of Dundee in 1991, an MSc from the University of Glasgow, an MBA from the University of Oxford, Diploma in Anaesthesia of the Royal College of Anaesthetists (DA RCA), Fellowship of the Royal College of Anaesthetists (FRCA) in 1996, Certificate of Completion of Specialist Training in Anaesthesia (UK) in 2002, Diploma in Intensive Care Medicine (FICM), Fellowship of the Faculty of Intensive Care Medicine (FFICM) in 2011, and Fellowship of the College of Intensive Care Medicine (FCICM) in 2022. He was appointed to his position at the University of Otago in 2015, having relocated to New Zealand in 2014 to lead the intensive care unit at Dunedin Hospital.

Carr's contributions to the field encompass clinical leadership, research, and professional service. As New Zealand Chair and executive member of the Australian and New Zealand Intensive Care Society (ANZICS), he has advanced critical care standards and policy. He contributed to the Coronavirus Disease 2019 ICU Multicriteria Decision Analysis Working Group, resulting in the 2021 publication 'Rapid Development of a Tool for Prioritizing Patients with Coronavirus Disease 2019 for Intensive Care' in Critical Care Explorations. Recent works include 'Redefining success: Incorporating long-term survival outcomes into routine benchmarking' in Critical Care Resuscitation (2025) and 'Building your future ICU in Asia Pacific: A structured regional priority-mapping summit report' in the Journal of Critical Care (2026). He is an author in Oh's Intensive Care Manual (9th Edition). Carr serves on Pharmac's expert advisory groups for intensive care and clinical pharmacology, and has delivered presentations at ANZICS conferences on ICU resilience, sustainability, and national clinical director roles, as well as at the World Federation of Paediatric Intensive and Critical Care Societies summit. His expertise has informed public discourse on ICU capacity expansion, staffing challenges, and frontline health worker vaccination during the COVID-19 pandemic.